Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

Pujol JL, Lavole A, Quoix E, Molinier O, Souquet PJ, Barlesi F, Le Caer H, Moro-Sibilot D, Fournel P, Oster JP, Chatellain P, Barre P, Jeannin G, Mourlanette P, Derollez M, Herman D, Renault A, Dayen C, Lamy PJ, Langlais A, Morin F, Zalcman G; French Cooperative Thoracic Intergroup (IFCT).; French Cooperative Thoracic Intergroup IFCT..

Ann Oncol. 2015 May;26(5):908-14. doi: 10.1093/annonc/mdv065. Epub 2015 Feb 16.

PMID:
25688059
2.

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.

Quoix E, Westeel V, Moreau L, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Sennelart H, Tredaniel J, Mennecier B, Morin F, Baudrin L, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique..

Eur Respir J. 2014 Jan;43(1):240-9. doi: 10.1183/09031936.00048213. Epub 2013 Oct 10.

3.

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B; Intergroupe Francophone de Cancérologie Thoracique..

Lancet. 2011 Sep 17;378(9796):1079-88. doi: 10.1016/S0140-6736(11)60780-0. Epub 2011 Aug 8.

PMID:
21831418
4.

Diminished cartilage creep properties and increased trabecular bone density following a single, sub-fracture impact of the rabbit femoral condyle.

Borrelli J Jr, Zaegel MA, Martinez MD, Silva MJ.

J Orthop Res. 2010 Oct;28(10):1307-14. doi: 10.1002/jor.21122.

5.

Single high-energy impact load causes posttraumatic OA in young rabbits via a decrease in cellular metabolism.

Borrelli J Jr, Silva MJ, Zaegel MA, Franz C, Sandell LJ.

J Orthop Res. 2009 Mar;27(3):347-52. doi: 10.1002/jor.20760.

6.

Effect of suture material and bone quality on the mechanical properties of zone I flexor tendon-bone reattachment with bone anchors.

Matsuzaki H, Zaegel MA, Gelberman RH, Silva MJ.

J Hand Surg Am. 2008 May-Jun;33(5):709-17. doi: 10.1016/j.jhsa.2008.01.025.

7.

PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling.

Thomopoulos S, Zaegel M, Das R, Harwood FL, Silva MJ, Amiel D, Sakiyama-Elbert S, Gelberman RH.

J Orthop Res. 2007 Oct;25(10):1358-68.

8.

Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model.

Thomopoulos S, Matsuzaki H, Zaegel M, Gelberman RH, Silva MJ.

J Orthop Res. 2007 Apr;25(4):473-9.

9.

Nicotine delays tendon-to-bone healing in a rat shoulder model.

Galatz LM, Silva MJ, Rothermich SY, Zaegel MA, Havlioglu N, Thomopoulos S.

J Bone Joint Surg Am. 2006 Sep;88(9):2027-34.

PMID:
16951120
10.

Early healing of flexor tendon insertion site injuries: Tunnel repair is mechanically and histologically inferior to surface repair in a canine model.

Silva MJ, Thomopoulos S, Kusano N, Zaegel MA, Harwood FL, Matsuzaki H, Havlioglu N, Dovan TT, Amiel D, Gelberman RH.

J Orthop Res. 2006 May;24(5):990-1000.

11.

Delayed repair of tendon to bone injuries leads to decreased biomechanical properties and bone loss.

Galatz LM, Rothermich SY, Zaegel M, Silva MJ, Havlioglu N, Thomopoulos S.

J Orthop Res. 2005 Nov;23(6):1441-7. Epub 2005 Aug 1.

12.

Supplementary core sutures increase resistance to gapping for flexor digitorum profundus tendon to bone surface repair - an in vitro biomechanical analysis.

Kusano N, Zaegel MA, Placzek JD, Gelberman RH, Silva MJ.

J Hand Surg Br. 2005 Jun;30(3):288-93. Epub 2005 Apr 8.

PMID:
15862370
13.

Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome).

Guichard C, Harricane MC, Lafitte JJ, Godard P, Zaegel M, Tack V, Lalau G, Bouvagnet P.

Am J Hum Genet. 2001 Apr;68(4):1030-5. Epub 2001 Feb 23.

14.

Standard combination versus alternating chemotherapy in small cell lung cancer: a randomised clinical trial including 394 patients. 'Petites Cellules' Group.

Urban T, Baleyte T, Chastang CL, Jeannin L, Delaval P, Zaegel M, Mornet M, Coetmeur D, Lebeau B.

Lung Cancer. 1999 Aug;25(2):105-13.

PMID:
10470844
15.

Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française.

Jacoulet P, Depierre A, Moro D, Rivière A, Milleron B, Quoix E, Ranfaing E, Anthoine D, Lafitte JJ, Lebeau B, Kleisbauer JP, Massin F, Fournel P, Zaegel M, Leclerc JP, Garnier G, Brambilla E, Capron F.

Ann Oncol. 1997 Oct;8(10):1009-14.

PMID:
9402175

Supplemental Content

Loading ...
Support Center